Intercellular Communication Is Key for Protective IFNα/β Signaling During Viral Central Nervous System Infection.


Journal

Viral immunology
ISSN: 1557-8976
Titre abrégé: Viral Immunol
Pays: United States
ID NLM: 8801552

Informations de publication

Date de publication:
Historique:
pubmed: 18 9 2018
medline: 21 5 2019
entrez: 18 9 2018
Statut: ppublish

Résumé

A variety of viruses can induce central nervous system (CNS) infections and neurological diseases, although the incidence is rare. Similar to peripheral infections, IFNα/β induction and signaling constitutes a first line of defense to limit virus dissemination. However, CNS-resident cells differ widely in their repertoire and magnitude of both basal and inducible components in the IFNα/β pathway. While microglia as resident myeloid cells have been implicated as prominent sentinels of CNS invading pathogens or insults, astrocytes are emerging as key responders to many neurotropic RNA virus infections. Focusing on RNA viruses, this review discusses the role of astrocytes as IFNα/β inducers and responders and touches on the role of IFNα/β receptor signaling in regulating myeloid cell activation and IFNγ responsiveness. A summary picture emerges implicating IFNα/β not only as key in establishing the classical "antiviral" state, but also orchestrating cell mobility and IFNγ-mediated effector functions.

Identifiants

pubmed: 30222502
doi: 10.1089/vim.2018.0101
pmc: PMC6350053
doi:

Substances chimiques

Interferon-alpha 0
Interferon-beta 77238-31-4
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Subventions

Organisme : NINDS NIH HHS
ID : P01 NS064932
Pays : United States

Références

J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
J Exp Med. 2010 Feb 15;207(2):327-37
pubmed: 20123961
J Virol. 2008 Jan;82(1):300-10
pubmed: 17928334
Glia. 2009 Aug 15;57(11):1239-49
pubmed: 19191334
J Virol. 2013 Mar;87(6):3382-92
pubmed: 23302888
Lab Anim Sci. 1986 Apr;36(2):130-5
pubmed: 3009966
Immunity. 2012 Apr 20;36(4):503-14
pubmed: 22520844
Pain. 2013 Oct;154(10):2185-97
pubmed: 23831863
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
Nat Med. 2013 Apr;19(4):458-64
pubmed: 23455712
J Virol. 2015 Dec 09;90(4):2031-8
pubmed: 26656686
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
J Exp Med. 1986 Apr 1;163(4):1030-5
pubmed: 2419472
J Virol. 2014 Apr;88(7):3695-704
pubmed: 24429359
Biochimie. 2007 Jun-Jul;89(6-7):770-8
pubmed: 17408841
mBio. 2014 Aug 26;5(5):e01476-14
pubmed: 25161189
J Neuroimmune Pharmacol. 2010 Sep;5(3):336-54
pubmed: 20369302
J Virol. 2012 Oct;86(20):11223-30
pubmed: 22875966
Viruses. 2009 Dec 1;1(3):689-712
pubmed: 20221421
Glia. 2008 Mar;56(4):426-35
pubmed: 18205173
J Virol. 2007 Dec;81(24):13668-80
pubmed: 17942530
J Exp Med. 1988 Mar 1;167(3):1171-85
pubmed: 2965208
Glia. 2009 Aug 15;57(11):1216-26
pubmed: 19191335
J Gen Virol. 2008 Jan;89(Pt 1):1-47
pubmed: 18089727
Trends Immunol. 2014 Feb;35(2):79-87
pubmed: 24316012
PLoS Pathog. 2013;9(5):e1003395
pubmed: 23737750
J Virol. 2014 Jan;88(2):1051-64
pubmed: 24198415
Cytokine Growth Factor Rev. 2002 Dec;13(6):441-54
pubmed: 12401479
Cell Mol Life Sci. 2017 Sep;74(18):3275-3291
pubmed: 28389721
mBio. 2010 Oct 19;1(4):
pubmed: 20978536
Trends Immunol. 2015 Oct;36(10):637-650
pubmed: 26431941
Nat Rev Microbiol. 2006 Feb;4(2):121-32
pubmed: 16415928
J Virol. 2015 Mar;89(5):2731-8
pubmed: 25540366
Glia. 2012 Oct;60(10):1555-66
pubmed: 22736486
J Clin Invest. 2017 Mar 1;127(3):843-856
pubmed: 28134626
J Exp Med. 2014 May 5;211(5):751-9
pubmed: 24752295
Cell Host Microbe. 2012 Jun 14;11(6):631-42
pubmed: 22704623
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Curr Opin Neurobiol. 2010 Oct;20(5):588-94
pubmed: 20655735
J Virol. 2011 Oct;85(19):10058-68
pubmed: 21752905
J Virol. 2008 Oct;82(20):9829-38
pubmed: 18667505
Curr Opin Virol. 2015 Apr;11:44-54
pubmed: 25681709
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
Cytokine Growth Factor Rev. 2016 Aug;30:95-101
pubmed: 27009077
Int J Cancer. 2014 Mar 15;134(6):1346-58
pubmed: 24154944
Cell Rep. 2017 May 9;19(6):1189-1201
pubmed: 28494868
J Virol. 2018 Apr 27;92(10):
pubmed: 29491163
Immunity. 2016 Mar 15;44(3):622-633
pubmed: 26921107
Biochimie. 2007 Jun-Jul;89(6-7):843-55
pubmed: 17544561
Viruses. 2013 Mar 15;5(3):834-57
pubmed: 23503326
Nat Rev Neurosci. 2016 Dec;17(12):766-776
pubmed: 27811921
J Immunol. 2009 Jan 15;182(2):1079-87
pubmed: 19124751
Brain Sci. 2013 Jul 22;3(3):1109-27
pubmed: 24961523

Auteurs

Mihyun Hwang (M)

Department of Neurosciences, Lerner Research Institute , Cleveland Clinic Foundation, Cleveland, Ohio.

Cornelia C Bergmann (CC)

Department of Neurosciences, Lerner Research Institute , Cleveland Clinic Foundation, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH